A protein-based prognostic model for pancreatic ductal adenocarcinoma: Construction and validation
Pancreatology · 2023
DOI: 10.1016/j.pan.2023.10.021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pancreatology, 2023. Verfasst von Yonghao Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Animal Research Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China; Zhejiang Provin…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Adenocarcinoma, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Zhejiang Provincial Health Commission, Medical Science and Technology Project of Zhejiang Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Probing relevant proteomic biomarkers may facilitate effective pancreatic adenocarcinoma (PDAC) diagnosis, treatment and prevention. Here, we developed a protein-based prognostic model for PDAC by using relevant proteomic biomarkers data from The Cancer Genome Atlas (TCGA). METHODS: We obtained PDAC's proteomic and clinical data from TCGA and used various analytical tools to identify differentially expressed proteins between normal and cancer tissues. We constructed our protein-based prognostic model and confirmed its accuracy using receiver operating characteristic curve and Kaplan-Meier survival analyses. We elucidated clinical factor-signature protein correlations by clinical correlation assessments and protein coexpression networks. We also used immunohistochemistry (protein expression assessment), Gene Set Enrichment Analysis (protein role identification) and CIBERSORT (infiltrating immune cell distribution assessment). RESULTS: CIITA, BRAF_pS445, AR, YTHDF2, IGFBP2 and CDK1_pT14 were identified as PDAC-associated prognostic proteins. All risk scores calculated using our model provided 1-, 3-, 5-year survival probability at 70 % accuracy. The reliability of our model was validated by the GEO as well. In high- and low-risk groups, age, sex, T- and N- stage disparities were significant, and prognostic and coexpressed proteins correlated. PDAC tissues demonstrated significant CDK1_pT14 overexpression but significant BRAF_pS445, YTHDF2, and IGFBP2 underexpression. Downstream proteins of BRAF were validated by IHC. Low-risk tissues demonstrated more naïve B cells, eosinophils, activated NK cells and regulatory T cells, whereas high-risk tissues demonstrated more activated memory T cells, monocytes, neutrophils, dendritic cells and resting NK cells. CONCLUSIONS: Our protein-based prognostic model for PDAC, along with six signature proteins, might aid in predicting PDAC prognosis and therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Animal Research Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, Hangzhou, 310003, China.
- Zhejiang Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
- Laboratory of Animal Research Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, Hangzhou, 310003, China; De…
- College of Life Sciences, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
- Zhejiang Provincial Key Laboratory of Pancreatic Disease, Hangzhou, 310003, China; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310…
- Laboratory of Animal Research Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
Förderung
- Zhejiang Provincial Health Commission
- Medical Science and Technology Project of Zhejiang Province
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Xu, Y., Wang, Y., Chen, Q., Yao, T., Qiu, J., Ni, L., Chen, H., & Liang, T. (2023). A protein-based prognostic model for pancreatic ductal adenocarcinoma: Construction and validation. Pancreatology. https://doi.org/10.1016/j.pan.2023.10.021
Vancouver
Xu Y, Wang Y, Chen Q, Yao T, Qiu J, Ni L, et al. A protein-based prognostic model for pancreatic ductal adenocarcinoma: Construction and validation. Pancreatology. 2023. doi:10.1016/j.pan.2023.10.021
BibTeX
@article{Xu2023,
author = {Xu, Yonghao and Wang, Yisu and Chen, Qi and Yao, Tao and Qiu, Junyu and Ni, Lei and Chen, Hui and Liang, Tingbo},
title = {A protein-based prognostic model for pancreatic ductal adenocarcinoma: Construction and validation},
journal = {Pancreatology},
year = {2023},
doi = {10.1016/j.pan.2023.10.021}
}
EUVIMED